×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [10]
内容类型
期刊论文 [10]
发表日期
2019 [1]
2018 [2]
2017 [4]
2016 [1]
2015 [1]
2013 [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共10条,第1-10条
帮助
限定条件
专题:中国医学科学院 北京协和医学院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Effect of a Quality of Care Improvement Initiative in Patients With Acute Coronary Syndrome in Resource-Constrained Hospitals in China A Randomized Clinical Trial
期刊论文
2019, 卷号: 4, 期号: 5, 页码: 418-427
作者:
Wu, Yangfeng
;
Li, Shenshen
;
Patel, Anushka
;
Li, Xian
;
Du, Xin
收藏
  |  
浏览/下载:219/0
  |  
提交时间:2020/01/03
Quality of life results from a randomized, double-blinded, placebo-controlled, multi-center phase III trial of anlotinib in patients with advanced non-small cell lung cancer
期刊论文
2018, 卷号: 122, 页码: 32-37
作者:
Si, Xiaoyan
;
Zhang, Li
;
Wang, Hanping
;
Zhang, Xiaotong
;
Wang, Mengzhao
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2020/01/03
Anlotinib
Non-small cell lung cancer
Quality of life
Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302)
期刊论文
2018, 卷号: 118, 期号: 5, 页码: 654-661
作者:
Han, Baohui
;
Li, Kai
;
Zhao, Yizhuo
;
Li, Baolan
;
Cheng, Ying
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2020/01/03
non-small-cell lung cancer
multitarget
tyrosine kinase inhibitor
anlotinib
third line
Efficacy and safety of third-line treatment with anlotinib in patients with refractory advanced non-small-cell lung cancer (ALTER-0303): a randomised, double-blind, placebo-controlled phase 3 study
期刊论文
2017, 卷号: 18, 页码: S3-S3
作者:
Han, Baohui
;
Li, Kai
;
Wang, Qiming
;
Zhao, Yizhuo
;
Zhang, Li
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/03
Genome-wide significant, replicated and functional risk variants for Alzheimer's disease
期刊论文
2017, 卷号: 124, 期号: 11, 页码: 1455-1471
作者:
Guo, Xiaoyun
;
Qiu, Wenying
;
Garcia-Milian, Rolando
;
Lin, Xiandong
;
Zhang, Yong
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2020/01/03
Alzheimer's disease
GWAS
Genome-wide significant
Replicated
Risk variant
Gene expression
APOE
A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
期刊论文
2017, 卷号: 12, 期号: 1, 页码: S886-S887
作者:
Han, Baohui
;
Li, Kai
;
Zhao, Yizhuo
;
Wang, Qiming
;
Zhang, Li
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2020/01/03
NSCLC
Anlotinib
multi-targeted tyrosine kinase inhibitor
Preliminary study on the diagnostic value of single-source dualenergy CT in diagnosing cervical lymph node metastasis of thyroid carcinoma
期刊论文
2017, 卷号: 9, 期号: 11, 页码: 4758-4766
作者:
Zhao, Yanfeng
;
Li, Xiaolu
;
Li, Lin
;
Wang, Xiaoyi
;
Lin, Meng
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/04
Thyroid carcinoma
lymph node
metastasis
spectral CT
Fungal biotransformation of tanshinone results in [4+2] cycloaddition with sorbicillinol: evidence for enzyme catalysis and increased antibacterial activity
期刊论文
2016, 卷号: 100, 期号: 19, 页码: 8349-8357
作者:
He, Wenni
;
Liu, Miaomiao
;
Li, Xiaolin
;
Zhang, Xiaoping
;
Abdel-Mageed, Wael M.
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2020/01/04
Biotransformation
[4+2] cycloaddition reaction
Tanshinone IIA
Hypocrea sp
The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm, Multi-Center, Prospective Study
期刊论文
2015, 卷号: 10, 期号: 11, 页码: e0142500
作者:
Hu, Xingsheng
;
Zhang, Li
;
Shi, Yuankai
;
Zhou, Caicun
;
Liu, Xiaoqing
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/13
Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial
期刊论文
2013, 卷号: 14, 期号: 10, 页码: 953-961
作者:
Shi, Yuankai
;
Zhang, Li
;
Liu, Xiaoqing
;
Zhou, Caicun
;
Zhang, Shucai
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2020/01/13
©版权所有 ©2017 CSpace - Powered by
CSpace